Incyte Corp
INCY- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000879169
In the last 90 days, Incyte Corp insiders filed 0 open-market purchases and 6 sales; 863 institutions reported holding it in 13F filings for Q2 2026, worth $23.0B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $24.5B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $34.3M in total
- 6
- 13F holdersQ2 2026, +51 vs. previous quarter
- 863
- 13F valueReported value at the end of Q2 2026
- $23.0B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $5.14B
- +21.2% year over year
- Net income, FY2025
- $1.29B
- +3,845.0% year over year
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $1.56B
- +14.0% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 10.6M
- Shares sold short
- Change
- +624.0K
- +6.2% vs. previous
- Days to cover
- 5.58
- At average daily volume
Superinvestors holding INCY, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding INCY at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Incyte Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 (view filing)4:07 PM ET | Nov 6 | 4 days | Stein Steven HCMO & Head of Late-Stage Dev. | SSale | −240.2K | $118.39 | −$28.4M | −88.6%30.9K after | 5 lots10b5-1 |
| Nov 5, 2026 (view filing)4:08 PM ET | Nov 3 | 2 days | Tray ThomasPrincipal Accounting Officer | SSale | −610 | $118.96 | −$72.6K | −2.8%21.1K after | 10b5-1 |
| Oct 19, 2026 (view filing)4:38 PM ET | Oct 15 | 4 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −2.64K | $112.71 | −$297.8K | −1.4%183.2K after | 10b5-1 |
| Sep 17, 2026 (view filing)4:04 PM ET | Sep 15 | 2 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −23.2K | $120.49 | −$2.80M | −11.2%183.2K after | 2 lots10b5-1 |
| Aug 20, 2026 (view filing)5:15 PM ET | Aug 19 | 1 day | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −10.8K | $125.56 | −$1.36M | −5.6%183.2K after | 10b5-1 |
| Aug 14, 2026 (view filing)4:01 PM ET | Aug 12 | 2 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −10.8K | $120.04 | −$1.30M | −5.3%194.0K after | 10b5-1 |
| Aug 7, 2026 (view filing)4:02 PM ET | Aug 5 | 2 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −10.6K | $122.69 | −$1.31M | −4.9%204.8K after | 10b5-1 |
| Aug 7, 2026 (view filing)4:01 PM ET | Aug 5 | 2 days | Mayes Patrick AEVP & Chief Scientific Officer | SSale | −2.21K | $123.99 | −$273.6K | −3.5%61.4K after | 10b5-1 |
| Aug 4, 2026 (view filing)4:04 PM ET | Jul 31 | 4 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −15.9K | $119.70 | −$1.90M | −6.9%215.4K after | 10b5-1 |
| Aug 4, 2026 (view filing)4:04 PM ET | Jul 31-Aug 3 | 4 days | Mayes Patrick AEVP & Chief Scientific Officer | SSale | −48.0K | $119.58 | −$5.73M | −43.8%61.4K after | 12 lots10b5-1 |
Top 10 13F holders, Q2 2026
See all 863 holdersThe largest institutional positions in Incyte Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 30,762,330 | $3.49B | 17.48% | +17,918+0.1% | Added |
| BlackRock, Inc. | 18,032,718 | $2.04B | 0.03% | −945,480−5.0% | Reduced |
| Dodge & Cox | 11,957,326 | $1.36B | 0.71% | −295,030−2.4% | Reduced |
| Vanguard Capital Management LLC | 11,024,289 | $1.25B | 0.03% | +94,223+0.9% | Added |
| State Street Corp | 9,722,336 | $1.10B | 0.03% | +80,952+0.8% | Added |
| Vanguard Portfolio Management LLC | 7,791,091 | $883.2M | 0.04% | +31,908+0.4% | Added |
| AQR Capital Management LLC | 5,320,901 | $603.2M | 0.21% | −487,029−8.4% | Reduced |
| Geode Capital Management, LLC | 4,750,735 | $536.5M | 0.03% | +47,551+1.0% | Added |
| LSV Asset Management | 4,123,759 | $467.5M | 0.85% | +203,703+5.2% | Added |
| Invesco Ltd. | 4,080,461 | $462.6M | 0.04% | +209,697+5.4% | Added |
Holders of 5% or more of INCY
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Incyte Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13D/A | 15.60%31.2M shares | −0.10 ppfrom 15.70% | May 18, 20219 filings | May 11, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.80%15.2M shares | – | Oct 21, 20243 filings | Oct 17, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 6.32%12.6M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
| Dodge & Cox | 13G/A | 6.20%12.3M shares | – | Feb 14, 20224 filings | May 14, 2026 | SEC |
| State Street Corp | 13G | 5.00%9.68M shares | – | Oct 17, 20242 filings | Nov 10, 2025 | SEC |
Politician trades
All politician trades in INCY3 members of Congress reported 4 trades in Incyte Corp since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| May 31, 2025 |  Robert P. Bresnahan, Jr. House · PA | Sell | $1K-$15K |
| Apr 17, 2023 |  Daniel S. Goldman House · NY | Sell | $1K-$15K |
| Jan 11, 2021 |  Gilbert Ray Cisneros, Jr. House · CA | Sell | $1K-$15K |
| Oct 14, 2020 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
House · PA · May 31, 2025
Sell$1K-$15K
House · NY · Apr 17, 2023
Sell$1K-$15K
House · CA · Jan 11, 2021
Sell$1K-$15K
House · CA · Oct 14, 2020
Buy$1K-$15K